Mometasone (as furoate monohydrate) 50mcg/spray. Mometasone is a corticosteroid ... symptoms in patients ≥2yrs of age. Prophylaxis of nasal symptoms of seasonal allergic rhinitis symptoms ...

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Naloxone comes as both a nasal spray and injection. It’s not immediately clear how the new drug will be used differently compared to naloxone, and some experts see potential downsides to its ...

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially ... this innovation could inspire a new generation of ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg. Developed by Glenmark, Ryaltris-AZ is a novel fixed-dose combination nasal spray of an anti-histamine and a ...

Mometasone (as furoate monohydrate) 50mcg/spray; contains benzalkonium ... within 7 days of starting use or new symptoms (eg, severe facial pain or thick nasal discharge) develop.